Literature DB >> 20153102

Long-term survival and characterisation of human umbilical cord-derived mesenchymal stem cells on dermal equivalents.

Rebekka K Schneider1, Andrea Püllen, Rafael Kramann, Jörg Bornemann, Ruth Knüchel, Sabine Neuss, Alberto Perez-Bouza.   

Abstract

During early embryogenesis, mesenchymal cells arise from the primitive epithelium and can revert to an epithelial phenotype by passing through mesenchymal-to-epithelial transition (MET). Mesenchymal stem cells (MSC) of the Wharton's Jelly of the umbilical cord (UC-MSC) express pluripotency markers underlining their primitive developmental state. As mesenchymal stem cells from bone marrow (BM-MSC) possess a strong propensity to ameliorate mesenchymal tissue damage, UC-MSC might also be able to differentiate into cells apart from the mesoderm, allowing replacement of ectodermal and mesodermal tissues. In this study, we analysed the possible epidermal differentiation of UC-MSC on dermal equivalents (DEs) consisting of collagen I/III with dermal fibroblasts and subjected to the culture conditions for tissue engineering of skin with keratinocytes. The culture conditions were further modified by pre-treating the cells with 5-azacytidine or by supplementing the medium with all trans retinoic acid. Interestingly, a subpopulation of UC-MSC (29%) co-expressed pan-cytokeratin (epithelial marker; pan-CK) and vimentin (mesenchymal marker) after isolation. Under the three-dimensional conditions of skin, the number of pan-CK(+)-cells increased to >30% after 21 days of cultivation, while under osteogenic culture conditions the cells were pan-CK-negative, thus showing the influence of the artificial niche. Nevertheless, the pan-CK-expression was neither accompanied by typical epithelial morphology nor expression of other epidermal markers. The pan-CK-detection can be explained by the expression of cytokeratins in myofibroblasts. UC-MSC expressed alpha-smooth muscle actin after isolation and displayed all features of functional myofibroblasts like morphology, cell-mediated contraction of a collagen gel and production of components of the extracellular matrix (ECM). The treatment with all trans retinoic acid or 5-azacytidine could neither induce an epidermal differentiation nor enhance the myofibroblastic differentiation. Concluding, UC-MSC might be an interesting cell source to support the regeneration of wounds by their differentiation into myofibroblasts and their extensive synthesis of ECM components. Copyright 2010 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153102     DOI: 10.1016/j.diff.2010.01.005

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  18 in total

Review 1.  Umbilical cord-derived mesenchymal stem cells: strategies, challenges, and potential for cutaneous regeneration.

Authors:  Siming Yang; Sha Huang; Changjiang Feng; Xiaobing Fu
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

2.  [Mesenchymal stem cells for bone tissue engineering].

Authors:  R K Schneider; S Neuss; R Knüchel; A Perez-Bouza
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

3.  Wharton's jelly stem cells: a novel cell source for oral mucosa and skin epithelia regeneration.

Authors:  Ingrid Garzón; Juliano Miyake; Miguel González-Andrades; Ramón Carmona; Carmen Carda; María del Carmen Sánchez-Quevedo; Antonio Campos; Miguel Alaminos
Journal:  Stem Cells Transl Med       Date:  2013-07-01       Impact factor: 6.940

4.  [Mesenchymal stroma cells and their niche].

Authors:  R K Schneider
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

5.  Human umbilical cord-derived mesenchymal stem cells differentiate into epidermal-like cells using a novel co-culture technique.

Authors:  Dongjie Li; Jiake Chai; Chuanan Shen; Yanfu Han; Tianjun Sun
Journal:  Cytotechnology       Date:  2014-06-21       Impact factor: 2.058

Review 6.  The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine.

Authors:  N Forraz; C P McGuckin
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

7.  Enhanced survival and neurite network formation of human umbilical cord blood neuronal progenitors in three-dimensional collagen constructs.

Authors:  Marian M Bercu; Hadar Arien-Zakay; Dana Stoler; Shimon Lecht; Peter I Lelkes; Simcha Samuel; Reuven Or; Arnon Nagler; Philip Lazarovici; Uriel Elchalal
Journal:  J Mol Neurosci       Date:  2012-12-12       Impact factor: 3.444

8.  Umbilical cord as a mesenchymal stem cell source for treating joint pathologies.

Authors:  Maria Carmen Arufe; Alexandre De la Fuente; Isaac Fuentes; Francisco Javier De Toro; Francisco Javier Blanco
Journal:  World J Orthop       Date:  2011-06-18

9.  Neural differentiation of human umbilical cord matrix-derived mesenchymal cells under special culture conditions.

Authors:  Parvin Salehinejad; Noorjahan Banu Alitheen; Abdul Manaf Ali; Abdul Rahman Omar; Mojgan Moshrefi; Batool Motamedi; Seyed Noureddin Nematollahi-Mahani
Journal:  Cytotechnology       Date:  2014-10-26       Impact factor: 2.058

Review 10.  Methodologies in creating skin substitutes.

Authors:  Mathew N Nicholas; Marc G Jeschke; Saeid Amini-Nik
Journal:  Cell Mol Life Sci       Date:  2016-05-06       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.